Syneron Medical Ltd. ELOS, the leading global aesthetic device company, announced today that
Asaf Alperovitz has resigned from the position of Chief Financial Officer to
pursue a new career opportunity. Syneron's Board of Directors has appointed
David Schlachet as interim Chief Financial Officer, effective as of August
24, 2012, and has initiated an executive search process to find a permanent
replacement.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in